157 related articles for article (PubMed ID: 9717724)
1. Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinflammatory agent, 5-aminosalicylic acid.
Batta AK; Tint GS; Xu G; Shefer S; Salen G
J Lipid Res; 1998 Aug; 39(8):1641-6. PubMed ID: 9717724
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory effects of 5-aminosalicylic acid conjugates with chenodeoxycholic acid and ursodeoxycholic acid on carrageenan-induced colitis in guinea-pigs.
Goto M; Okamoto Y; Yamamoto M; Aki H
J Pharm Pharmacol; 2001 Dec; 53(12):1711-20. PubMed ID: 11804402
[TBL] [Abstract][Full Text] [Related]
3. Hydrolysis and absorption of a conjugate of ursodeoxycholic acid with para-aminobenzoic acid.
Maeda Y; Takahashi M
J Pharmacobiodyn; 1989 Dec; 12(12):744-53. PubMed ID: 2635732
[TBL] [Abstract][Full Text] [Related]
4. Basic studies on 5-(7-hydroxy-3-O-phosphonocholyl)aminosalicylic acid for the evaluation of microbial overgrowth.
Konishi T; Takahashi M; Ohta S
Biol Pharm Bull; 1997 Apr; 20(4):370-5. PubMed ID: 9145212
[TBL] [Abstract][Full Text] [Related]
5. The rapid evaluation of intestinal bacterial growth using a conjugate of ursodeoxycholic acid with para-aminobenzoic acid.
Maeda Y; Takahashi M; Tashiro H; Akazawa F
J Pharmacobiodyn; 1989 May; 12(5):272-80. PubMed ID: 2810016
[TBL] [Abstract][Full Text] [Related]
6. [Basic studies on the utility of ursodeoxycholic acid derivatives for clinical medicine].
Konishi T
Yakugaku Zasshi; 2000 Jan; 120(1):1-15. PubMed ID: 10655778
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.
Ward JBJ; Lajczak NK; Kelly OB; O'Dwyer AM; Giddam AK; Ní Gabhann J; Franco P; Tambuwala MM; Jefferies CA; Keely S; Roda A; Keely SJ
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G550-G558. PubMed ID: 28360029
[No Abstract] [Full Text] [Related]
8. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
[TBL] [Abstract][Full Text] [Related]
9. Intestinal absorption and metabolism of homoursodeoxycholic acid in rats.
Kuramoto T; Moriwaki S; Kawamoto K; Hoshita T
J Pharmacobiodyn; 1987 Jul; 10(7):309-16. PubMed ID: 3694424
[TBL] [Abstract][Full Text] [Related]
10. Intestinal fate of 5-aminosalicylic acid: regional and systemic kinetic studies in relation to inflammatory bowel disease.
Bondesen S
Pharmacol Toxicol; 1997; 81 Suppl 2():1-28. PubMed ID: 9396082
[No Abstract] [Full Text] [Related]
11. Use of the conjugate of disulphated ursodeoxycholic acid with p-aminobenzoic acid for the detection of intestinal bacteria.
Takahashi M; Konishi T; Maeda Y; Matsugu Y; Akazawa F; Eto T; Okajima M; Uchida K; Masaoka Y; Okada K
Gut; 1993 Jun; 34(6):823-8. PubMed ID: 8314517
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
Van den Bossche L; Hindryckx P; Devisscher L; Devriese S; Van Welden S; Holvoet T; Vilchez-Vargas R; Vital M; Pieper DH; Vanden Bussche J; Vanhaecke L; Van de Wiele T; De Vos M; Laukens D
Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28115375
[TBL] [Abstract][Full Text] [Related]
13. Metabolic fate and hepatocyte toxicity of reverse amide analogs of conjugated ursodeoxycholate in the rat.
Coleman JP; Kirby LC; Setchell KD; Hylemon PB; Pandak M; Heuman DM; Vlahcevic ZR
J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):91-101. PubMed ID: 9569014
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies of metabolism of simultaneously administered chenodeoxycholic acid and ursodeoxycholic acid in hamsters.
Kihira K; Yamauchi T; Kuramoto T; Une M; Yoshii M; Hoshita T
Steroids; 1994 Jul; 59(7):431-5. PubMed ID: 7974527
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, intestinal absorption and metabolism of sarcosine conjugated ursodeoxycholic acid.
Kimura M; Hatono S; Une M; Fukuoka C; Kuramoto T; Hoshita T
Steroids; 1984 Jun; 43(6):677-87. PubMed ID: 6533845
[TBL] [Abstract][Full Text] [Related]
16. A new simple test for evaluation of intestinal bacteria.
Takahashi M; Maeda Y; Tashiro H; Eto T; Goto T; Sanada O
World J Surg; 1990; 14(5):628-34; discussion 635. PubMed ID: 2238664
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent antiinflammatory effect of ursodeoxycholic acid in experimental colitis.
Martínez-Moya P; Romero-Calvo I; Requena P; Hernández-Chirlaque C; Aranda CJ; González R; Zarzuelo A; Suárez MD; Martínez-Augustin O; Marín JJ; de Medina FS
Int Immunopharmacol; 2013 Feb; 15(2):372-80. PubMed ID: 23246254
[TBL] [Abstract][Full Text] [Related]
18. Colonic N-acetylation of 5-aminosalicylic acid in inflammatory bowel disease.
Allgayer H; Ahnfelt NO; Kruis W; Klotz U; Frank-Holmberg K; Söderberg HN; Paumgartner G
Gastroenterology; 1989 Jul; 97(1):38-41. PubMed ID: 2566551
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic carboxypeptidase hydrolysis of bile acid-amino conjugates: selective resistance of glycine and taurine amidates.
Huijghebaert SM; Hofmann AF
Gastroenterology; 1986 Feb; 90(2):306-15. PubMed ID: 2867000
[TBL] [Abstract][Full Text] [Related]
20. Intestinal absorption of ursodeoxycholic acid in children and adolescents with inflammatory bowel disease.
Fujisawa T; Kimura A; Ushijima K; Nakashima E; Inoue T; Yamashita Y; Kato H
J Pediatr Gastroenterol Nutr; 1998 Mar; 26(3):279-85. PubMed ID: 9523862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
